News
02-24-2011, 09:11 PM
BioSante Pharmaceuticals, Inc. today announced that enrollment of subjects in the first of two pivotal Phase III LibiGel safety and efficacy trials has been completed.
More... (http://www.news-medical.net/news/20110224/BioSante-completes-patient-enrollment-in-LibiGel-Phase-III-trial-for-treatment-of-FSD.aspx)
More... (http://www.news-medical.net/news/20110224/BioSante-completes-patient-enrollment-in-LibiGel-Phase-III-trial-for-treatment-of-FSD.aspx)